West Nile Virus Neuroinvasive Disease in Patients Treated With Anti-CD20 Therapies
Authors:
- Rumyar V. ArdakaniRARumyar V. Ardakani
- Paul Daniel CranePCPaul Daniel Crane
- Daniel M. PastulaDPDaniel M. Pastula
- Elizabeth MatthewsEMElizabeth Matthews
- Kelli M. MoneyKMKelli M. Money
- Anna ShahASAnna Shah
- Amanda L. PiquetAPAmanda L. Piquet
- Robert H. GrossRGRobert H. Gross
- Aaron M. CarlsonACAaron M. Carlson
- Kenneth L. TylerKTKenneth L. Tyler
- John R. CorboyJCJohn R. Corboy
- 1 August 2025
- journal article
- Published by Wolters Kluwer Health in Neurology Clinical Practice
- Vol. 15 (4) , e200489
Abstract
The literature on severe West Nile virus (WNV) neuroinvasive disease (WNND) in patients treated with anti-CD20 therapies is limited. We systematically characterize cases of WNND in the tertiary academic UCHealth system. A retrospective cohort (January 2016 to January 2024) of patients with a validated diagnosis of WNND and anti-CD20 medication use was identified with electronic medical record query followed by individual chart review. We identified 25 patients; multiple sclerosis was the most common indication for anti-CD20 therapy in 13 patients (52%). Twenty-one patients (84%) presented with meningoencephalitis. CSF WNV IgM was positive in 5 of 21 patients (24%) who were tested while 13 of 14 tested patients (93%) had positive reverse-transcription PCR (RT-PCR) findings in the CSF. MRI demonstrated anomalies associated with WNND in 12 of 23 patients (52%) with available imaging. Intensive care unit admission was required in 8 patients (32%), and 12 patients (48%) were treated with intravenous immunoglobulin. Worsening of ≥1 point from pre-WNV baseline modified Rankin Scale (mRS) score to the 90-day postdischarge mRS score was seen in 18 patients (75%). Two patients (8%) died by 90 days. WNND leads to disability accrual in patients on B cell-depleting anti-CD20 therapies. Utilization of RT-PCR is important in optimizing diagnosis in this patient population because of limited sensitivity of the WNV-IgM testing commonly used in the general population.Keywords
All Related Versions
This publication has 25 references indexed in Scilit:
- The Neurocognitive and MRI Outcomes of West Nile Virus Infection: Preliminary Analysis Using an External Control GroupFrontiers in Neurology, 2018
- Use of Testing for West Nile Virus and Other ArbovirusesEmerging Infectious Diseases, 2016
- Long-Term Neurological Outcomes in West Nile Virus–Infected Patients: An Observational StudyThe American Journal of Tropical Medicine and Hygiene, 2015
- Survival Analysis, Long-Term Outcomes, and Percentage of Recovery up to 8 Years Post-Infection among the Houston West Nile Virus CohortPLOS ONE, 2014
- West Nile Virus: Review of the LiteratureJAMA, 2013
- Association between Cerebral Performance Category, Modified Rankin Scale, and discharge disposition after cardiac arrestResuscitation, 2011
- West Nile virus encephalitis acquired via liver transplantation and clinical response to intravenous immunoglobulin: case report and review of the literatureTransplant Infectious Disease, 2011
- CSF findings in 250 patients with serologically confirmed West Nile virus meningitis and encephalitisNeurology, 2006
- West Nile Virus Meningoencephalitis: MR Imaging Findings2005
- Possible benefit of intravenous immunoglobulin therapy in a lung transplant recipient with West Nile virus encephalitisTransplant Infectious Disease, 2002